PLoS ONE,
Год журнала:
2020,
Номер
15(10), С. e0240149 - e0240149
Опубликована: Окт. 2, 2020
From
January
2020,
COVID-19
is
spreading
around
the
world
producing
serious
respiratory
symptoms
in
infected
patients
that
some
cases
can
be
complicated
by
severe
acute
syndrome,
sepsis
and
septic
shock,
multiorgan
failure,
including
kidney
injury
cardiac
injury.
Cost
time
efficient
approaches
to
reduce
burthen
of
disease
are
needed.
To
find
potential
treatments
among
whole
arsenal
existing
drugs,
we
combined
system
biology
artificial
intelligence-based
approaches.
The
drug
combination
pirfenidone
melatonin
has
been
identified
as
a
candidate
treatment
may
contribute
virus
infection.
Starting
from
different
targets
effect
drugs
converges
on
human
proteins
with
known
role
SARS-CoV-2
infection
cycle.
Simultaneously,
GUILDify
v2.0
web
server
used
an
alternative
method
corroborate
against
SARS-CoV-2.
We
have
also
predicted
therapeutic
over
associated
pathology,
thus
tackling
at
same
two
important
issues
COVID-19.
These
evidences,
together
fact
medical
point
view
both
considered
safe
current
standard
care
for
makes
this
very
attractive
treating
stage
II,
non-severe
symptomatic
presence
those
who
risk
developing
pulmonary
complications.
Frontiers in Molecular Neuroscience,
Год журнала:
2024,
Номер
17
Опубликована: Июнь 12, 2024
Stroke
is
a
devastating
disease
with
high
morbidity,
disability,
and
mortality,
among
which
ischemic
stroke
more
common.
However,
there
still
lack
of
effective
methods
to
improve
the
prognosis
reduce
incidence
its
complications.
At
present,
evidence
that
peripheral
organs
are
involved
in
inflammatory
response
after
stroke.
Moreover,
interaction
between
central
inflammation
includes
activation
resident
immune
cells,
as
well
inflammation-related
signaling
pathways,
all
play
an
important
role
pathophysiology
In
this
review,
we
discuss
mechanisms
stroke,
interactions
through
circulatory
pathways
(such
gut,
heart,
lung
spleen)
brain
mediate
regulate
We
also
propose
potential
meningeal
lymphatic
vessels
(MLVs)-cervical
lymph
nodes
(CLNs)
brain-peripheral
crosstalk
pathway
addition,
summarize
anti-inflammatory
drugs
treatment
Cardiovascular
disease
is
the
cause
of
physical
infirmity
and
thousands
deaths
annually.
Typically,
during
heart
failure,
cardiomyocyte
mitochondria
falter
in
terms
energy
production
metabolic
processing.
Additionally,
inflammation
accumulation
non-contractile
fibrous
tissue
contribute
to
cardiac
malfunction.
Melatonin,
an
endogenously
produced
molecule,
experimentally
reduces
initiation
progression
atherosclerotic
lesions,
which
are
often
basis
coronary
artery
disease.
The
current
review
critically
analyzes
published
data
related
experimental
use
melatonin
forestall
pathologies.
Collectively,
these
studies
document
melatonin’s
anti-atherosclerotic
actions
reducing
LDL
oxidation
triglyceride
levels,
lowering
endothelial
malfunction,
limiting
adhesion
molecule
formation,
preventing
macrophage
polarization
M1
pro-inflammatory
phenotype,
changing
cellular
metabolism,
scavenging
destructive
reactive
oxygen
species,
proliferation
invasion
arterial
smooth
muscle
cells
into
lesioned
area,
restricting
ingrowth
blood
vessels
from
vasa
vasorum,
solidifying
plaque
cap
reduce
chance
its
rupture.
Diabetic
hyperglycemia,
aggravates
also
inhibited
by
supplementation
animals.
potential
value
non-toxic
as
a
possible
inhibitor
pathology
humans
should
be
seriously
considered
performing
clinical
trials
using
this
multifunctional
molecule.
PLoS ONE,
Год журнала:
2020,
Номер
15(10), С. e0240149 - e0240149
Опубликована: Окт. 2, 2020
From
January
2020,
COVID-19
is
spreading
around
the
world
producing
serious
respiratory
symptoms
in
infected
patients
that
some
cases
can
be
complicated
by
severe
acute
syndrome,
sepsis
and
septic
shock,
multiorgan
failure,
including
kidney
injury
cardiac
injury.
Cost
time
efficient
approaches
to
reduce
burthen
of
disease
are
needed.
To
find
potential
treatments
among
whole
arsenal
existing
drugs,
we
combined
system
biology
artificial
intelligence-based
approaches.
The
drug
combination
pirfenidone
melatonin
has
been
identified
as
a
candidate
treatment
may
contribute
virus
infection.
Starting
from
different
targets
effect
drugs
converges
on
human
proteins
with
known
role
SARS-CoV-2
infection
cycle.
Simultaneously,
GUILDify
v2.0
web
server
used
an
alternative
method
corroborate
against
SARS-CoV-2.
We
have
also
predicted
therapeutic
over
associated
pathology,
thus
tackling
at
same
two
important
issues
COVID-19.
These
evidences,
together
fact
medical
point
view
both
considered
safe
current
standard
care
for
makes
this
very
attractive
treating
stage
II,
non-severe
symptomatic
presence
those
who
risk
developing
pulmonary
complications.